Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.100
+0.105 (5.26%)
Oct 13, 2026, 12:36 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 143.75 million as of October 12, 2026. It is the 39,773rd most valuable company in the world and the 559th biggest in Sweden. Its market cap has decreased by 34.98% in one year.
Market Cap
143.75M
Enterprise Value
132.79M
Revenue
n/a
Global Rank
Country Rank
#559 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 143.75M, an increase of 185.41%. That is a compound annual growth rate of 11.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 143.75M | -29.05% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 154.60M |
| Diamyd Medical AB | 151.88M |
| Simris Group AB (PUBL) | 150.50M |
| Abera Bioscience AB | 140.62M |
| Alzinova AB | 133.45M |
| NextCell Pharma AB | 127.91M |
| OncoZenge AB | 115.37M |
| Ascelia Pharma AB | 114.84M |